Free Trial

Semler Scientific (NASDAQ:SMLR) Shares Down 5.6% - What's Next?

Semler Scientific logo with Medical background

Shares of Semler Scientific, Inc. (NASDAQ:SMLR - Get Free Report) were down 5.6% during mid-day trading on Friday . The stock traded as low as $67.33 and last traded at $67.82. Approximately 586,094 shares were traded during mid-day trading, an increase of 108% from the average daily volume of 281,545 shares. The stock had previously closed at $71.84.

Semler Scientific Stock Down 6.5 %

The stock has a 50-day moving average of $43.82 and a 200 day moving average of $34.79. The company has a market capitalization of $556.77 million, a PE ratio of 32.77 and a beta of 1.18.

Semler Scientific (NASDAQ:SMLR - Get Free Report) last announced its quarterly earnings data on Monday, November 4th. The company reported $0.72 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.37 by $0.35. The firm had revenue of $13.51 million during the quarter. Semler Scientific had a return on equity of 20.31% and a net margin of 27.00%.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in SMLR. Sanctuary Advisors LLC purchased a new stake in shares of Semler Scientific during the 3rd quarter worth approximately $104,000. Geode Capital Management LLC grew its holdings in Semler Scientific by 10.5% during the third quarter. Geode Capital Management LLC now owns 135,959 shares of the company's stock valued at $3,202,000 after purchasing an additional 12,964 shares during the period. Jane Street Group LLC increased its position in Semler Scientific by 72.3% in the third quarter. Jane Street Group LLC now owns 16,982 shares of the company's stock worth $400,000 after buying an additional 7,126 shares during the last quarter. State Street Corp raised its stake in shares of Semler Scientific by 0.6% in the third quarter. State Street Corp now owns 118,223 shares of the company's stock valued at $2,784,000 after buying an additional 725 shares during the period. Finally, Verition Fund Management LLC purchased a new position in shares of Semler Scientific during the 3rd quarter valued at $251,000. 49.37% of the stock is currently owned by hedge funds and other institutional investors.

About Semler Scientific

(Get Free Report)

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.

Further Reading

Should you invest $1,000 in Semler Scientific right now?

Before you consider Semler Scientific, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Semler Scientific wasn't on the list.

While Semler Scientific currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines